# NeuroAegis Phase 4A-C: Final Test Zero-Leakage Audit
**Timestamp:** 2026-09-06T16:54:22Z  
**Commit:** `17943cdaccfa1d6857f787b91e53b223dbbb8616`  
**Status:** **PASS (Mutually Disjoint Partitioning Verified)**

## 1. Patient Partition Invariants
- **Training Patients (N=16):** chb04, chb09, chb11, chb12, chb13, chb14, chb15, chb16, chb17, chb18, chb19, chb20, chb21, chb22, chb23, chb24
- **Validation Patients (N=4):** chb06, chb07, chb08, chb10
- **Test Patients (N=4):** chb01, chb02, chb03, chb05
- `TRAIN ∩ TEST`: $\emptyset$ (Overlaps: 0)
- `VALIDATION ∩ TEST`: $\emptyset$ (Overlaps: 0)
- `TRAIN ∩ VALIDATION`: $\emptyset$ (Overlaps: 0)

## 2. Recording & Window Invariants
- **Recordings:** Train (449), Val (82), Test (155) -> Mutually disjoint.
- **Windows:** Train (901,391), Val (293,410), Test (219,909) -> Mutually disjoint.

## 3. Data Scope Invariants
- Correlation matrix estimated exclusively on continuous unlabelled training recordings.
- Zero test data used for graph construction, normalization, threshold selection, or model checkpointing.
- Model checkpoint frozen prior to single test pass.
